Viewing Study NCT06595069



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06595069
Status: COMPLETED
Last Update Posted: None
First Post: 2024-09-10

Brief Title: A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult Patients
Sponsor: None
Organization: None

Study Overview

Official Title: A Single-Center Retrospective Observational Study to Assess the Characteristics and the Real-World Long-Term Effectiveness of Inclisiran in Chinese Adult Patients
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This was a single-center retrospective observational study non-interventional study with secondary use of data among patients in a real-world setting

This study used the medical record data from patients in Yiling Eligible patients who newly initiated inclisiran from 26 January 2022 to 21 August 2023 were included The retrospective data up to the date of ethics committee approval April 2024 was collected The study team collected patient data using an electronic case report form eCRF from April 2024 to June 2024
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: